Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment

Brain Research

Volumn 783, Issue 1, 1998, Pages 133-142

  Reid, Malcolm S ^a   Ho, Lauren B ^a   Tolliver, Bryan K ^a   Wolkowitz, Owen M ^a   Berger, S Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Dopamine; Metyrapone; Restraint stress; Sensitization

Indexed keywords

AMPHETAMINE; CORTICOSTERONE; DOPAMINE; METYRAPONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CORTICOSTERONE RELEASE; DOPAMINE RELEASE; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STEREOTYPY; STRESS;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORTICOSTERONE; MALE; METYRAPONE; MICRODIALYSIS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; STEREOTYPED BEHAVIOR; STRESS;

EID: 0031889517     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01319-X     Document Type: Article

References (58)

1. Abrahamsen G.C., Carr K.D. Effects of corticosteroid synthesis inhibitors on the sensitization of rewards by food restriction. Brain Res. 726:1996;39-48.
2. Antelman S.M., Eichler A.J., Black C.A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 207:1980;329-331.
3. Bozarth M.A., Murray A., Wise R.A. Influence of housing conditions on the acquisition of intravenous heroin and cocaine elf-administration in rats. Pharmacol. Biochem. Behav. 33:1989;903-907.
4. Bradbury M.J., Cascio C.S., Scribner K.A., Dallman M.F. Stress-induced adrenocorticotropin secretion: diurnal responses and decreases during stress in the evening are not dependent on corticosterone. Endocrinology. 128:1991;680-688.
5. Cador M., Cole B.J., Koob G.F., Stinus L., LeMoal M. Central administration of corticotrophin releasing factor induces long-term sensitization to D-amphetamine. Brain Res. 606:1993;181-186.
6. Chart J.J., Sheppard H. Amphenone analogues as adrenal cortical inhibitors. J. Med. Pharmaceut. Chem. 1:1959;407-441.
7. Cole B.J., Cador M., Stinus L., Rivier J., Vale W., Koob G.F., LeMoal M. Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res. 512:1990;343-346.
8. B. Costall, R.J. Naylor, Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rat, in: E.H. Ellinwood, M.M. Kilbey (Eds.), Cocaine and Other Stimulants, Plenum, New York, 1977, pp. 47-76.
9. Deroche V., Piazza P.V., Casolini P., Maccari S., Le Moal M., Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res. 598:1992;343-348.
10. Deroche V., Piazza P.V., Maccari S., Le Moal M., Simon H. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res. 584:1992;309-313.
11. Deroche V., Piazza P.V., Casolini P., LeMoal M., Simon H. Sensitization to the psychomotor effects of amphetamine and morphine induced by food restriction depend on corticosterone secretion. Brain Res. 611:1993;352-356.
12. Deroche V., Marinelli M., Maccari S., LeMoal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids: I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7181-7188.
13. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16:1996;274-282.
14. Hamamura T., Akiyama K., Akimoto K., Kashihara K., Okumura K., Ujike H., Otsuki S. Co-administration of either selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546:1991;40-46.
15. Heidbreder C.A., Thompson A.C., Shippenberg T.S. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 278:1996;490-502.
16. Herman J.-P., Stinus L., Le Moal M. Repeated stress increases locomotor response to amphetamine. Psychopharmacology. 84:1984;431-435.
17. Hooks M.S., Jones G.H., Sith A.D., Neill D.B., Justice J.B. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse. 9:1991;121-128.
18. Horger B.A., Giles M.K., Schenk S. Pre-exposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology. 107:1992;271-276.
19. Jenkins J.S., Meakin J.W., Nelson D.H., Thorn G.W. Inhibition of adrenal steroid 11-oxygenation in the dog. Science. 128:1958;478-479.
20. Kalivas P.W., Duffy P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol. Psychol. 25:1989;913-928.
21. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine: I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
22. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
23. Karler R., Calder L.D., Turkanis S.A. DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552:1991;295-300.
24. Kimura K., Nimokos G.G., Svensson T.H. Effects of amperozide on psychostimulant-induced hyperlocomotion and dopamine release in the nucleus accumbens. Pharmacol. Biochem. Behav. 44:1993;27-36.
25. Kolta M.G., Shreve P., De Souza V., Utresky N.J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24:1985;823-829.
26. Maccari S., Piazza P.V., Deminiere J.M., Lemaire V., Mormede P., Simon H., Angelucci L., LeMoal M. Life events-induced decrease of type I corticosteroid receptors is associated with a decrease of corticosterone feedback and an increase of the vulnerability to amphetamine self-administration. Brain Res. 547:1991;7-12.
27. MacLennan A.J., Maier S.F. Coping and stress-induced potentiation of stimulant stereotypy in the rat. Science. 219:1983;1091-1093.
28. Marinelli M., LeMoal M., Paizza P.V. Acute pharmacological blockade of corticosterone secretion reverses food restriction-induced sensitization of the locomotor response to cocaine. Brain Res. 724:1996;251-255.
29. Marinelli M., Rouge-Pont F., De Jesus-Oliviera C., LeMoal M., Piazza P.V. Acute blockade of corticosterone secretion decreases the psychomotor stimulant effects of cocaine. Neuropsychopharmacology. 16:1997;156-161.
30. Ottenweller J.E., Servatius R.J., Natelson B.H. Repeated stress persistently elevates morning, but not evening, plasma corticosterone levels in male rats. Physiol. Behav. 55:1994;337-340.
31. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
32. G. Paxinos C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
33. Piazza P.V., Deminiere J.-M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
34. Piazza P.V., Deminiere J.-M., Le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
35. Piazza P.V., Deminiere J.-M., Maccari M., Mormede P., Le Moal M., Simon H. Individual reactivity to novelty predicts the probability of amphetamine self-administration. Behav. Pharmacol. 1:1990;339-345.
36. Piazza P.V., Marinelli M., Jodogne C., Deroche V., Rouge-Pont F., Maccari S., LeMoal M., Simon H. Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 658:1994;259-264.
37. Piazza P.V., Maccari S., Deminiere J.-M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. USA. 88:1991;2088-2092.
38. Piazza P.V., LeMoal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids and dopaminergic neurons. Ann. Rev. Pharmacol. Toxicol. 36:1996;359-378.
39. Pierce R.C., Bell K., Duffy P., Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16:1996;1550-1560.
40. Post R.M. Cocaine psychoses: a continuum model. Am. J. Psychiatry. 132:1975;225-231.
41. Reid M.S., Berger S.P. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. NeuroReport. 7:1996;1325-1329.
42. Reid M.S., Hsu K., Tolliver B.K., Berger S.P. Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization. J. Pharmacol. Exp. Ther. 276:1996;1244-1256.
43. Reid M.S., Ho L.B., Berger S.P. Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis. Psychopharmacology. 126:1996;301-310.
44. M.S. Reid, K. Hsu, S.P. Berger, Stimulants preferentially increase glutamate release in the limbic system: studies on the involvement of dopamine, Synapse, 1997 (in press).
45. Robinson T.E., Angus A.L., Becker J.B. Sensitization to stress: the enduring effects of prior stress on amphetamine induced rotational behavior. Life Sci. 37:1985;1039-1042.
46. Robinson T., Becker J. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
47. Robinson T.E., Becker J.B., Young E.A., Akil H., Castaneda E. The effects of footshock stress on regional brain dopamine metabolism and pituitary β-endorphin release in rats previously sensitized to amphetamine. Neuropharmacology. 26:1987;679-691.
48. Roozendaal B., Carmi O., McGaugh J.L. Adrenocortical suppression blocks the memory enhancing effects of amphetamine and epinephrine. Proc. Natl. Acad. Sci. USA. 93:1996;1429-1433.
49. Rouge-Pont F., Marinelli M., LeMoal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids: II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7189-7195.
50. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock on extracellular dopamine levels in the ventral striatum. Brain Res. 559:1991;26-31.
51. Snyder S.H. Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines. Am. J. Psychiatry. 130:1973;61-67.
52. Steketee J.D., Kalivas P.W. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. J. Pharmacol. Exp. Ther. 2661:1992;811-818.
53. Tolliver B.K., Belknap J.K., Woods W.E., Carney J.M. Genetic analysis of sensitization and tolerance to cocaine. J. Pharmacol. Exp. Ther. 270:1994;1230-1238.
54. Tolliver B.K., Ho L.B., Reid M.S., Berger S.P. Evidence for dissociable mechanisms of amphetamine and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment. Psychopharmacology. 126:1996;191-198.
55. Valadez A., Schenk S. Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration. Pharmacol. Biochem. Behav. 47:1994;203-205.
56. Vezina P., Herve D., Glowinski J., Tassin J.P. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci. Lett. 186:1994;111-114.
57. Wolf M.E., Xue C.-J., White F.J., Dahlin S.L. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res. 666:1994;223-231.
58. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264:1993;249-255.